Sebastian D.

Founding Principal at Arconex Capital

📍 United States🔄 Updated September 2026💼 4 investments📅 12 years investing🗓 Last invested Jan 2025
VC🌍 United States
4
Total investments
2
Early stage
1
Mid stage
0
Late stage
12y
Years active

Portfolio

4 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor, Advisor
2025
A Sales, Guest Management, and Discovery Platform for Boutique and Independent Hotels: Do More. Make More. With Less
Investor, Techstars 2024 Cohort Startup
2023
A network for entrepreneurs building in stealth. Submit your information here so investors can find you: harmonic.ai/get-discovered
Investor
2015
Quantgene decentralizes genomics to bring precision medicine to everyone. Our turnkey genomics platform empowers hospitals to move life-saving genomic diagnostics inside their organizations, unlock powerful new sources of revenue and become a driving force in clinical discovery. From complete genomic profiling to hereditary cancer testing and multi-cancer early detection, we help hospitals, physicians and patients to unlock the full power of precision genomics.
early stageBiotechnology
Investor
2014
Bitcoin is an open source peer to peer electronic cash system. Because the code is open source, the idea is public domain and the name, symbol and concept is all considered a public good, it has functioned fully for 14+ years without a centralized entity baby sitting its existence. Bitcoin is not only an open source software project, a new digital asset within its own class, a peer to peer computational system, the largest computer network on earth, but it is also the bedrock of a new government, a new form of society & the foundation for a modern civilization. Our company was formed to further that mission, that goal and that purpose of Bitcoin, without anyone permission or approval, to use the Bitcoin brand, name and technology, to fulfil the potentiality of Bitcoin. By creating the tools, products & services in the original vision of the Satoshi Client, we provide the essential parts of Bitcoin to the public, to institutions and the world at large. Bitcoin Wallets Bitcoin Nodes Bitcoin Miners operated & owned by our benevolent dictator Morgan Rockwell @Nodefather
mid stageUtilities
Experience · 8 entries
All (8)
Investments (4)
Founder (2)
2025
Investor, Advisor
2025
A Sales, Guest Management, and Discovery Platform for Boutique and Independent Hotels: Do More. Make More. With Less
2024
Founder, CEO, CTO
2024
Arconex - Vertical AI SaaS for the Architecture, Engineering & Construction (AEC) Industry. The $1.8TN AEC industry has traditionally faced intrinsic barriers to technological disruption. These have limited the adoption of Vertical SaaS. Tech stacks are often old. Data lives in messy and siloed legacy systems. It is typically unstructured in the form of construction contracts, drawings, bids and un-captured communications. There is a high degree of fragmentation. The largest construction firm in the US has 1% market share. These factors contribute to the industrys high friction and inefficiency. AI has now made this foundational industry accessible. Arconex - towards seamless AEC.
2023
Investor, Techstars 2024 Cohort Startup
2023
A network for entrepreneurs building in stealth. Submit your information here so investors can find you: harmonic.ai/get-discovered
2018
Founding Principal
2018
Arconex Capital is a private investment firm founded in 2018. Our focus is AEC industry consolidation, technology and the overlap between them. We believe companies can benefit from more than just capital and liquidity. We generate value for our portfolio companies by leveraging Arconex’s relationships, expertise, industry knowledge, and network of resources and connections. Our mission is to encourage a more efficient, stable and consistent AEC industry for the benefit of all stakeholders.
2015
Investor
2015
Quantgene decentralizes genomics to bring precision medicine to everyone. Our turnkey genomics platform empowers hospitals to move life-saving genomic diagnostics inside their organizations, unlock powerful new sources of revenue and become a driving force in clinical discovery. From complete genomic profiling to hereditary cancer testing and multi-cancer early detection, we help hospitals, physicians and patients to unlock the full power of precision genomics.
early stageBiotechnology
Show all 8 entries ↓
Investment activity
2014–2025 · 4 investments
20141201512023120251
Recent (last 2 years)Earlier